OTC ophthalmic demulcents
This article was originally published in The Tan Sheet
FDA denies March 1989 petition from Alcon Labs requesting that the agency amend the OTC ophthalmic demulcents final monograph to include Dextran 75.1% when used with another polymeric demulcent drug. "Adequate physico-chemical information" must be submitted and approved before Dextran 75 can be included in combination with another ingredient, FDA said in a recent letter, and "at least two adequate and well-controlled studies" are needed to include Dextran 75 as the sole demulcent ingredient in OTC ophthalmic products
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC